|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Protara Therapeutics (NASDAQ: TARA) through any online brokerage.
The latest price target for Protara Therapeutics (NASDAQ: TARA) was reported by HC Wainwright & Co. on June 4, 2021. The analyst firm set a price target for 40.00 expecting TARA to rise to within 12 months (a possible 293.31% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Protara Therapeutics (NASDAQ: TARA) is $10.17 last updated Tue Jun 22 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Protara Therapeutics.
There is no upcoming split for Protara Therapeutics.
Protara Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.